Quarterly report · Q1
8086.TEDINET S100RNZX
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥140.6bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥545.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥127.9bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥7.3bn | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥3.0bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥8.9bn | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥15.3bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.3bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥9.4bn | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥9.0bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.1bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥5.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.4bn | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥5.7bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥1.04T | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥1.03T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥947.6bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥791.5bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥785.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥249.2bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥242.2bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥217.3bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥88.1bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥89.7bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥25.14 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.05 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.35 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥22.27 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥24.85 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.66 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 20.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 20.1% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-06-30 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-06-30 | ¥189m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥971m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-06-30 | ¥3m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥14.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥14.5bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥8.2bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥109.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥108.0bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥11.8bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥27.8bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥17.4bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥10.3bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥3.2bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥16.6bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥15.0bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥566m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥153.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥140.4bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥13.5bn |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥155.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥140.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥14.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥15.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-06-30 | ¥154m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥855m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-06-30 | ¥211m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥9.3bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥7.1bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥99.3bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥97.7bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.6bn |
| jpcrp040300-q1r_E02688-000Medical Treatment Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥8.5bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥23.2bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥17.9bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥5.3bn |
| jpcrp040300-q1r_E02688-000Medicine Relatedreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥407m |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥12.2bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q1r_E02688-000Pharma Packagingreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥1.0bn |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥136.2bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥8.4bn |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥137.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥127.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥9.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥10.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 446
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)海南監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)石 原 美 保 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 林 裕 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)船 城 公 教 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 127892000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 140594000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 545199000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 7337000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 8901000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 15346000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 5275000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 4099000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 4574000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 19483000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 8514000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 25980000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 217251000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 249197000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 242173000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 947561000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 1040678000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1027399000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 32.35 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 25.14 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 28.05 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 28.66 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 22.27 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 24.85 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.213 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.205 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.201 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 171459479 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 171459479 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 171459479 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 171459479 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 7763000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 1635957 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 163595700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 100779 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 171459479 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 1635957 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 7763000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 7763000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |